Summit Therapeutics Inc.

SMMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$17.19

+$0.29 (+1.72%)

Sep 22, 2026, 2:19 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-801.23M	-176.85M	-486.63M	-64.22M	-65.68M	-38.71M
Depreciation & Amortization	108.36K	71.12K	156.69K	1.03M	1.82M	1.47M
Stock-Based Compensation	543.57M	40.74M	11.16M	9.74M	9.49M	1.3M
Other Working Capital	11.96M	10.33M	-5.78M	3.74M	6.52M	2.31M
Other Non-Cash Items	-5.44M	10.12M	414.97M	11.51M	610.07K	145.43K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	23.32M	12.37M	-408.34K	8.04M	-49.67K	454.66K
Operating Cash Flow	-239.67M	-113.56M	-60.74M	-33.9M	-53.81M	-35.34M
Capital Expenditures	-487.6K	-111.07K	-101.29K	-508.68K	-226.83K	-309.23K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-359.94M	-543.41M	-254.04M	n/a	n/a	n/a
Sales Maturities Of Investments	231.06M	391.42M	164.73M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-11.99M	-375.73M	n/a	n/a	n/a
Investing Cash Flow	-129.37M	-164.09M	-465.14M	-508.68K	-226.83K	-309.23K
Debt Repayment	n/a	-79.91M	-19.54M	423.9M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-489.85K	-126.36K	-127.5K	404.71K
Financial Cash Flow	458.31M	304.63M	68.46M	505.62M	57.76M	37.13M
Net Cash Flow	89.35M	26.98M	-456.76M	470.22M	3.98M	1.89M
Free Cash Flow	-240.15M	-113.67M	-60.85M	-34.41M	-54.03M	-35.65M
Adj. Free Cash Flow	-783.73M	-154.4M	-72.01M	-44.15M	-63.53M	-36.94M
Maintenance CapEx	-487.6K	-111.07K	-101.29K	-508.68K	-135.94K	-307.61K
Growth CapEx	n/a	n/a	n/a	n/a	-90.89K	-1.62K
Owner Earnings	-240.15M	-113.67M	-60.85M	-34.41M	-53.94M	-35.65M